Cited 6 times in
Complications, treatments, and visual prognosis of choroidal osteomas
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김성수 | - |
dc.contributor.author | 김용준 | - |
dc.contributor.author | 변석호 | - |
dc.contributor.author | 이준원 | - |
dc.contributor.author | 최은영 | - |
dc.contributor.author | 이승규 | - |
dc.contributor.author | 고형준 | - |
dc.date.accessioned | 2022-12-22T01:54:17Z | - |
dc.date.available | 2022-12-22T01:54:17Z | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 0721-832X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/191385 | - |
dc.description.abstract | Purpose: This study aims to report complications, treatments, and visual prognosis of choroidal osteoma. Methods: We retrospectively reviewed electronic medical records and multimodal images of 41 patients with choroidal osteoma. Results: Visually significant complications included choroidal neovascularization (CNV) in 21 (47.7%) eyes and subretinal fluid (SRF) without CNV in 14 (31.8%) eyes. The most common treatment was intravitreal anti-vascular endothelial growth factor (VEGF) injection: 13 (61.9%) eyes with CNV received an average of 6.3 injections, and 6 (42.9%) eyes with SRF but without CNV received 1.8 injections. As the first-line treatment, intravitreal anti-VEGF injection induced complete or partial remission in 93.4% of eyes with CNV and 57.1% of eyes with SRF. The probability of legally low vision estimated at 3 and at 5 years was 29.1% and 34.2%, respectively. The presence of CNV and outer retinal tubulation (ORT) was independent risk factors for vision loss (adjusted odds ratio, 8.08 and 6.94, respectively). Conclusions: The development of CNV and ORT was strong risk factors for visual impairment. Due to the frequent recurrence of complications and poor visual prognosis, regular check-ups and appropriate treatment choices are warranted. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English, German | - |
dc.publisher | Springer-Verlag | - |
dc.relation.isPartOf | GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Angiogenesis Inhibitors / therapeutic use | - |
dc.subject.MESH | Choroidal Neovascularization* / drug therapy | - |
dc.subject.MESH | Fluorescein Angiography | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Intravitreal Injections | - |
dc.subject.MESH | Osteoma* / complications | - |
dc.subject.MESH | Osteoma* / diagnosis | - |
dc.subject.MESH | Osteoma* / drug therapy | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Ranibizumab | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Tomography, Optical Coherence | - |
dc.subject.MESH | Vascular Endothelial Growth Factor A | - |
dc.subject.MESH | Visual Acuity | - |
dc.title | Complications, treatments, and visual prognosis of choroidal osteomas | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학교실) | - |
dc.contributor.googleauthor | Hyo Jin Seong | - |
dc.contributor.googleauthor | Yong Joon Kim | - |
dc.contributor.googleauthor | Eun Young Choi | - |
dc.contributor.googleauthor | Junwon Lee | - |
dc.contributor.googleauthor | Suk Ho Byeon | - |
dc.contributor.googleauthor | Sung Soo Kim | - |
dc.contributor.googleauthor | Hyoung Jun Koh | - |
dc.contributor.googleauthor | Sung Chul Lee | - |
dc.contributor.googleauthor | Christopher Seungkyu Lee | - |
dc.identifier.doi | 10.1007/s00417-021-05487-4 | - |
dc.contributor.localId | A00571 | - |
dc.contributor.localId | A05821 | - |
dc.contributor.localId | A01849 | - |
dc.contributor.localId | A03179 | - |
dc.contributor.localId | A05056 | - |
dc.contributor.localId | A02913 | - |
dc.contributor.localId | A00152 | - |
dc.relation.journalcode | J00951 | - |
dc.identifier.eissn | 1435-702X | - |
dc.identifier.pmid | 34762167 | - |
dc.identifier.url | https://link.springer.com/article/10.1007/s00417-021-05487-4 | - |
dc.subject.keyword | Choroidal neovascularization | - |
dc.subject.keyword | Choroidal osteoma | - |
dc.subject.keyword | Intravitreal injection | - |
dc.subject.keyword | Photodynamic therapy | - |
dc.subject.keyword | Subretinal fluid | - |
dc.contributor.alternativeName | Kim, Sung Soo | - |
dc.contributor.affiliatedAuthor | 김성수 | - |
dc.contributor.affiliatedAuthor | 김용준 | - |
dc.contributor.affiliatedAuthor | 변석호 | - |
dc.contributor.affiliatedAuthor | 이준원 | - |
dc.contributor.affiliatedAuthor | 최은영 | - |
dc.contributor.affiliatedAuthor | 이승규 | - |
dc.contributor.affiliatedAuthor | 고형준 | - |
dc.citation.volume | 260 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1713 | - |
dc.citation.endPage | 1721 | - |
dc.identifier.bibliographicCitation | GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, Vol.260(5) : 1713-1721, 2022-05 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.